The topic isn’t about other countries. Quite frankly, I don’t know much about what other countries do in this regard. It may be much less expensive for them to bring a drug to market if they can bypass a lot of what the FDA requires in this country. I also don’t know if other countries allow for lawsuits against the manufacturer of the drugs to the extent we see here in the United States. There are a lot of variables at play in what ultimately becomes the “cost” of the drug.

However, I do know that if a private industry, they have to make a profit which is then reinvested in the next drug that shows potential.

Whether one likes the profit they make or not , it is the way our system is set up.